ActiTrexx
Munich, Germany· Est.
WELCOME TO ACTITREXX At ActiTrexx we are developing novel therapies based on activated regulatory T cells (Treg). We aim to bring back tolerance to patients with dysfunctional immune system. Our goal is to tackle the root cause of autoimmune and autoinflammatory diseases, and
Private Company
Total funding raised: $2.3M
About
WELCOME TO ACTITREXX At ActiTrexx we are developing novel therapies based on activated regulatory T cells (Treg). We aim to bring back tolerance to patients with dysfunctional immune system. Our goal is to tackle the root cause of autoimmune and autoinflammatory diseases, and
Cell & Gene Therapy
Funding History
2Total raised:$2.3M
Grant$500K
Seed$1.8M